Recurrent Ovarian Cancer: Treatment Guidance After Cancer Returns скачать в хорошем качестве

Recurrent Ovarian Cancer: Treatment Guidance After Cancer Returns

Genetic Alliance and Luna are partnering with Travera, a company whose mission is to bring hope to late-stage cancer patients who are running out of time and therapeutic options. Travera is offering its 2-day Rapid Therapy Guidance™ test to women with late-stage ovarian cancer free of charge to help in their efforts to establish an ovarian cancer database. Travera assists oncologists in selecting treatments for their patients with our revolutionary cancer therapy guidance test that predicts which cancer drugs are most likely to be effective for each cancer patient. Using a disruptive single-cell measurement technology invented at MIT that measures the ex vivo growth response of live tumor cells to candidate drugs, Travera has overcome the problems that have prevented the many previous generations of therapy guidance tests from being effective in clinical practice. Presenters: Dr. Cliff Reid, Ph.D - Travera Founder & CEO Sharon Terry - Genetic Alliance President & CEO Travera and LunaDNA will help, just notify them of your interest. • Seeking more information is no commitment to test. • LunaDNA link: https://id.lunadna.com/referrer/peer-... • Travera contact form: https://www.travera.com/geneticalliance